India Glycols Demerges into Three Entities Effective September 1, 2026
India Glycols Limited demerged into three entities effective September 1, 2026: India Glycols Limited, IGL Spirits Limited, and Ennature Bio Pharma Limited. Shareholders will receive shares in each new entity based on their holdings as of September 2, 2026.
A demerger into three separate listed entities is a major corporate action that fundamentally restructures the company, impacting its operations, management, and shareholder value. This will have a significant effect on the company's future prospects and investor perception.
The announcement details a corporate restructuring (demerger) which is a significant event but does not inherently carry positive or negative financial implications without further performance data. The impact is neutral as it reorganizes the business structure.
India Glycols Limited (IGL) has announced the effectiveness of its Scheme of Arrangement, leading to its demerger into three distinct entities: India Glycols Limited, IGL Spirits Limited, and Ennature Bio Pharma Limited. This scheme, sanctioned by the Hon’ble National Company Law Tribunal (NCLT), became effective on September 1, 2026, after the filing of the certified true copy of the NCLT order with the Registrar of Companies, Uttarakhand.
The original entity, India Glycols Limited, will now house the chemicals, glycols, bio-glycols, new specialty products, and industrial gases businesses. IGL Spirits Limited will focus on the spirits business, including IMFL, country liquor, and bio-fuel. Ennature Bio Pharma Limited will encompass the bio-pharma and bio-polymers businesses.
Shareholders are set to receive shares in each of the new entities. As per the record date of September 2, 2026, shareholders will receive one equity share of IGL Spirits Limited for every one equity share held in India Glycols Limited, and one equity share of Ennature Bio Pharma Limited for every three equity shares held in India Glycols Limited. This restructuring aims to create companies with clear business focuses, enabling improved management oversight, efficient resource allocation, and optimized capital utilization.
A plain-language summary of a public exchange filing by India Glycols Limited. Read the original for the full detail.